Affluent Medical S.A.
AFME.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €4,118 | €1,224 | €1,339 | €1,451 |
| % Growth | 236.4% | -8.6% | -7.7% | – |
| Cost of Goods Sold | €13,390 | €2,424 | €2,443 | €2,741 |
| Gross Profit | -€9,272 | -€1,200 | -€1,104 | -€1,290 |
| % Margin | -225.2% | -98% | -82.4% | -88.9% |
| R&D Expenses | €0 | €0 | €52 | €23 |
| G&A Expenses | €13,707 | €11,787 | €5,162 | €5,189 |
| SG&A Expenses | €13,803 | €11,866 | €5,243 | €5,209 |
| Sales & Mktg Exp. | €96 | €79 | €81 | €20 |
| Other Operating Expenses | -€7,354 | €0 | €7,905 | €6,022 |
| Operating Expenses | €6,449 | €11,866 | €13,200 | €11,254 |
| Operating Income | -€15,689 | -€13,066 | -€11,883 | -€13,233 |
| % Margin | -381% | -1,067.5% | -887.5% | -912% |
| Other Income/Exp. Net | -€392 | -€3,944 | -€3,517 | -€2,010 |
| Pre-Tax Income | -€16,081 | -€17,010 | -€15,400 | -€15,257 |
| Tax Expense | -€1,342 | -€1,357 | -€173 | -€437 |
| Net Income | -€14,739 | -€15,653 | -€15,227 | -€14,820 |
| % Margin | -357.9% | -1,278.8% | -1,137.2% | -1,021.4% |
| EPS | -0.37 | -0.54 | -0.81 | -0.8 |
| % Growth | 31.5% | 33.3% | -1.3% | – |
| EPS Diluted | -0.37 | -0.54 | -0.81 | -0.8 |
| Weighted Avg Shares Out | 39,346 | 28,987 | 18,887 | 18,592 |
| Weighted Avg Shares Out Dil | 39,346 | 29,092 | 18,887 | 18,592 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €1,061 | €3,036 |
| Interest Expense | €242 | €393 | €1,080 | €3,055 |
| Depreciation & Amortization | €2,396 | €2,055 | €2,450 | €2,420 |
| EBITDA | -€13,443 | -€13,343 | -€13,214 | -€10,888 |
| % Margin | -326.4% | -1,090.1% | -986.9% | -750.4% |